FDA Cybersecurity Requirements Decoded

If you're responsible for getting a medical device through FDA clearance—or for designing one with a robust cybersecurity posture—this guide is for you.

Quality and Regulatory Affairs teams need clarity on what FDA actually requires versus what's mentioned in the myriad of guidance documents. You're accountable for the success of submissions, and cybersecurity deficiencies are increasingly common reasons for rejection.

R&D and Design Engineering teams need to know what to build into the device—and when. Retrofitting cybersecurity controls after design freeze is expensive and delays timelines.

The challenge is that FDA's cybersecurity guidance spans multiple documents, references numerous standards, and uses terminology that can obscure rather than clarify. This guide cuts through that complexity.

Design process controls that actually work

The checkbox problem: Design controls often become an afterthought—a paperwork exercise to complete before submission rather than tools that shape the design. This approach leads to predictable consequences:

  • Late-stage surprises: Verification testing reveals the design doesn't meet requirements that were never properly specified.
  • Validation gaps: Vague User Needs mean Design Validation cannot demonstrate the device meets them, leading to weak rationales and FDA inquiries.
  • Traceability holes: Auditors find requirements without evidence or tests without linked requirements.
  • 483 observations: Design control deficiencies remain among the most cited findings in FDA warning letters year after year.

Quality and Regulatory Affairs teams struggle to move engineering beyond a "paperwork" mindset to achieve true compliance.

R&D and Design Engineering teams need design controls to help catch problems early and clarify requirements rather than slowing them down.

Project Managers must plan these activities into schedules so milestones become meaningful decision points.